1Debra M, Eckert, Peter S. Kim Mechanisms of viralmembrane fusion and its inhibition[J]. Annu Rev Biochem, 2001, 70:777-810
2Shibo Jiang, Qian Zhao, Asim K. Debnath Peptide and Non-peptide HIV F usion Inhibitor[J]. Current Pharm Design, 2002, 8:563-580
3Rapaport D, Ovadia M, Shai Y. A synthetic peptide corresponding to a c ons erved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: a n emerging similarity with functional domains of other viruses[J]. EMBO J, 19 95, 14:5524-5531
4Pinon JD, Kelly SM, Price NC, et al. An antiviral pept ide targets a coiled-coil domain of the human T-cell leukemia virus envelope glyc oprotein[J]. J Virol, 2003,77:3281-3290
5Marra MA, Jones SJ, Astell CR, et al. The Genome Sequence of t he SARS-Associated Coronavirus[online]. May 1, 2003[Cited 2003-05-22] . Available from Science (http://www.sciencemag.org/cgi/rapidpdf/1085953v1.pdf)
6Rota PA, Oberste MS, Monroe SS, et al. Characterization of a No vel Cor onavirus Associated with Severe Acute Respiratory Syndrome[online]. May 1, 2003[Cited 2003-05-22] . Available from Science (http://www.sciencemag.org/cgi/rapidpdf/1085952v1.pdf)
7Chambers P, Pringle CR, Easton AJ. Heptad repeat sequences are located adjace nt to hydrophobic regions in several types of virus fusion glycoproteins[J]. J Gen Virol, 1990,71 (12):3075-3080
